The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

 The work reported was supported by cooperative agreement grants and contracts from the National Institute of Mental Health to the following: University of California, Berkeley: U01 MH50461, N01MH12009, and HHSN271200800005-C; Duke University: U01 MH50477, N01MH12012, and HHSN271200800009-C; University of California, Irvine: U01 MH50440, N01MH 12011, and HHSN271200800006-C; Research Foundation for Mental Hygiene (New York State Psychiatric Institute/Columbia University): U01 MH50467, N01 MH12007, and HHSN271200800007-C; Long Island-Jewish Medical Center U01 MH50453; New York University: N01MH12004 and HHSN271200800004-C; University of Pittsburgh: U01 MH50467, N01MH12010, and HHSN271200800008-C; and McGill University N01MH12008 and HHSN271200800003-C. The Office of Special Education Programs of the U.S. Department of Education, the Office of Juvenile Justice and Delinquency Prevention of the Justice Department, and the National Institute on Drug Abuse also participated in funding.The opinions and assertions contained in this report are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of Health and Human Services, the National Institutes of Health, or the National Institute of Mental Health.This article is the subject of an editorial by Dr. Philip L. Hazell in this issue.Clinical trial registration information—Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000388.

PII: S0890-8567(09)60066-6

doi: 10.1097/CHI.0b013e31819c23d0

© 2009 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.